GEISTLICH PHARMA

geistlich-pharma-logo

Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, their respected family-owned Swiss parent company has pioneered technological advances that make regenerative treatment, with safe and naturally sourced biomaterials, the preferred choice for clinical predictability.

#SimilarOrganizations #People #Website #More

GEISTLICH PHARMA

Industry:
Biotechnology Health Care Medical

Founded:
1851-01-01

Address:
Princeton, New Jersey, United States

Country:
United States

Website Url:
http://www.geistlich-pharma.com

Total Employee:
501+

Status:
Active

Contact:
(855) 799-5500

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Google Tag Manager Font Awesome Apache Amazon Google Maps JsDelivr Cloudflare JS


Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

Current Employees Featured

not_available_image

Gudrun Denke
Gudrun Denke Deputy Director Preclinical and Clinical Research & Development @ Geistlich Pharma
Deputy Director Preclinical and Clinical Research & Development
2007-05-01

urs-iten_image

Urs Iten
Urs Iten CIO / Director Group IT @ Geistlich Pharma
CIO / Director Group IT
2020-09-01

Founder


peter-geistlich_image

Peter Geistlich

Official Site Inspections

http://www.geistlich-pharma.com Semrush global rank: 1.98 M Semrush visits lastest month: 10.84 K

  • Host name: gate64.pd056.proserver.punkt.de
  • IP address: 138.201.149.158
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Geistlich Pharma"

About Us - Geistlich Pharma AG

The Swiss MedTech company Geistlich develops, produces and distributes medical products for the regeneration of bone, cartilage and tissue. IN ACTION FOR REGENERATION Our โ€ฆSee details»

Our Company - Geistlich Pharma AG

Geistlich Pharma AG Bahnhofstrasse 40 CH - 6110 Wolhusen. Phone: +41 41 492 55 55 Fax: +41 41 492 56 39 [email protected]. ... As part of the Geistlich Group, we develop, produce โ€ฆSee details»

Geistlich USA: Company

Geistlich Pharma North America Inc. 400 Alexander Park Drive, Suite 302 Princeton, NJ 08540 USA. Geistlich Dental Customer Care Phone: 855-799-5500 (Toll-free) Geistlich Medical (Advanced Wound Care | Surgical and Sports โ€ฆSee details»

Geistlich Pharma - Crunchbase Company Profile & Funding

Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, their respected family-owned Swiss parent company has โ€ฆSee details»

Informs you even better โ€“ the new website of Geistlich โ€ฆ

Apr 7, 2014 The new website of Geistlich Pharma AG has been live since today. With the re-launch, the information content has been tailored even more specifically to the information โ€ฆSee details»

Geistlich Pharma North America, Inc. - The Org

Geistlich Pharma North America, Inc., is an affiliate of Geistlich Pharma AG who produce and distribute medical devices and pharmaceuticals for regenerative medicine in Wolhusen and โ€ฆSee details»

Geistlich Pharma | LinkedIn

Geistlich Pharma | 13.028 Follower:innen auf LinkedIn. Geistlich is a global leader dedicated to advancing regenerative medicine. Geistlich has been the world market leader in the field of regenerative dentistry for many years. In addition, โ€ฆSee details»

Geistlich Pharma AG Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Geistlich Pharma AG of Wolhusen, LUZERN. Get the latest business insights from Dun & Bradstreet.See details»

About Us - Geistlich Pharma AG

Geistlich Sons Limited Thorley House, Bailey Lane, Manchester Airport, GB - Manchester M90 4AB. Phone: +44 161 490 2038 Fax: +44 161 498 6988 ... Geistlich Pharma Our Company โ€ฆSee details»

Geistlich Pharma AG - Swiss Biotech

Geistlich Pharma is specialized in biomaterials for the regeneration of bone, cartilage and tissue and develops and manufactures medical devices and pharmaceuticals with the goal of giving โ€ฆSee details»

Geistlich Pharma - Overview, News & Similar companies

Who is Geistlich Pharma. Geistlich's regenerative medical devices aim to improve patients' quality of life. More than 750 employees worldwide work for Geistlich in the area of regenerative โ€ฆSee details»

Geistlich Pharma Company Profile - Office Locations ... - Craft

Geistlich Pharma is a producer, developer, and distributor of medical devices and drugs. It offers biomaterials, dental, surgical orthopedics, sports and spinal medicine, dentistry, oral, โ€ฆSee details»

Geistlich Pharma - Funding, Financials, Valuation

Geistlich Pharma has acquired 2 organizations. Their most recent acquisition was Bionnovation Biomedical on Apr 5, 2024. Which types of acquisition does this organization make most โ€ฆSee details»

Geistlich USA: United States

Geistlich Pharma North America Inc. 400 Alexander Park Drive, Suite 302 Princeton, NJ 08540 USA. Geistlich Dental Customer Care Phone: 855-799-5500 (Toll-free) Geistlich Medical โ€ฆSee details»

Geistlich Pharma North America - Overview, News

Mar 15, 2023 Geistlich Pharma and its 3 business units Geistlich Biomaterials, Geistlich Surgery, Geistlich Medical have 10 subsidiaries and global distribution, over 500 employees worldwide โ€ฆSee details»

Geistlich Pharma partners with StimLabs for wound care โ€ฆ

1 day ago Geistlich Pharma has entered an exclusive national distribution collaboration agreement with StimLabs in the US, focusing on the commercialisation of the formerโ€™s โ€ฆSee details»

Our History - Geistlich Pharma AG

In 2013, Dr. Peter Geistlich and Geistlich Pharma launched the Osteo Science Foundation based in the US. Its declared goal is to support independent basic and applied research and enable โ€ฆSee details»

Geistlich Pharma North America, Inc. acquires Lynch โ€ฆ

Oct 26, 2022 For Immediate Release: Princeton, New Jersey October 26, 2022: Geistlich Pharma North America announced today the acquisition of Lynch Biologics, LLC, the โ€ฆSee details»

Nivolumab in Patients With Advanced or Metastatic โ€ฆ

3 days ago PURPOSETo report on CheckMate 627 (ClinicalTrials.gov identifier: NCT02832167), a phase II adaptive basket design trial of nivolumab in uncommon advanced/metastatic โ€ฆSee details»

Impressive results for Geistlich Pharma in 2020 despite โ€ฆ

Mar 22, 2021 Associated with the measures introduced worldwide to optimize costs and achieve greater flexibility, Geistlichโ€™s very good annual results in 2020 are impressive given the โ€ฆSee details»

linkstock.net © 2022. All rights reserved